Status:
UNKNOWN
Treatment of Trigger Finger With Steroid Injection Versus Steroid Injection and Splinting
Lead Sponsor:
The Philadelphia & South Jersey Hand Center
Conditions:
Trigger Finger
Stenosing Tenosynovitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hypothesis: Treatment of trigger finger by corticosteroid injection and splinting is superior to corticosteroid treatment alone.
Detailed Description
Stenosing tenosynovitis, or more commonly "trigger finger" is a disease that can severely impact a patient's quality of life. Its incidence is said to be 28 persons per 100,000 annually. The disease i...
Eligibility Criteria
Inclusion
- Trigger finger in one or more trigger fingers, in stages 2 to 5 (inclusive)
- Adult patient aged over 18 years.
- No prior treatment (splinting, injection or surgery) to the involved finger OR at least 1 year since last treatment of the involved finger.
Exclusion
- Exclude Trigger thumbs because they appear to be respond very favorably or unfavorably to treatment3
- Exclude locked digits because surgery is indicated in these cases
- Pregnant patients
- Prisoners
- Patients with impaired decision-making capacity
- Patients that do not speak English and cannot fill in English language questionnaires.
Key Trial Info
Start Date :
May 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01886157
Start Date
May 1 2013
End Date
May 1 2016
Last Update
March 18 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Philadelphia and South Jersey Hand Center
Philadelphia, Pennsylvania, United States, 19107